Co-Encapsulation and Co-Delivery of Peptide Drugs via Polymeric Nanoparticles

Combination therapy is a promising form of treatment. In particular, co-treatment of P3 and QBP1 has been shown to enhance therapeutic effect in vivo in treating polyglutamine diseases. These peptide drugs, however, face challenges in clinical administration due to poor stability, inability to reach...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ma Rie, Feng, Teng, Zhang, Qian, Chan, Ho Yin Edwin, Chau, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419018/
https://www.ncbi.nlm.nih.gov/pubmed/30960272
http://dx.doi.org/10.3390/polym11020288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419018/
https://www.ncbi.nlm.nih.gov/pubmed/30960272
http://dx.doi.org/10.3390/polym11020288

Ejemplares similares